Vascular endothelial growth factor polymorphisms in patients with steroid-induced femoral head osteonecrosis

Journal of Orthopaedic Research

Volumn 30, Issue 1, 2012, Pages 21-27

  Lee, Yun Jong ^a,b   Lee, Jong Seok ^a,b   Kang, Eun Ha ^a   Lee, Young Kyun ^a,b   Kim, Shin Yoon ^c   Song, Yeong Wook ^b   Koo, Kyung Hoi ^a,b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c Kyungpook National University School of Medicine   (South Korea)

Author keywords

femoral head; osteonecrosis; polymorphism; vascular endothelial growth factor

Indexed keywords

STEROID; VASCULOTROPIN;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; FEMUR HEAD NECROSIS; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

5' UNTRANSLATED REGIONS; ADULT; AGED; FEMALE; FEMUR HEAD NECROSIS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLUCOCORTICOIDS; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREVALENCE; PROMOTER REGIONS, GENETIC; REPUBLIC OF KOREA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 81555201501     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21492     Document Type: Article

References (42)

1. Mont MA, Jones LC, Hungerford DS,. 2006. Nontraumatic osteonecrosis of the femoral head: ten years later. J Bone Joint Surg Am 88: 1117-1132.
2. Kerachian MA, Seguin C, Harvey EJ,. 2009. Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol 114: 121-128.
3. Kerachian MA, Harvey EJ, Cournoyer D, et al. 2006. Avascular necrosis of the femoral head: vascular hypotheses. Endothelium 13: 237-244. (Pubitemid 44463532)
4. Kim HK, Bian H, Randall T, et al. 2004. Increased VEGF expression in the epiphyseal cartilage after ischemic necrosis of the capital femoral epiphysis. J Bone Miner Res 19: 2041-2048. (Pubitemid 41103419)
5. Radke S, Battmann A, Jatzke S, et al. 2006. Expression of the angiomatrix and angiogenic proteins CYR61, CTGF, and VEGF in osteonecrosis of the femoral head. J Orthop Res 24: 945-952. (Pubitemid 43804929)
6. Kabata T, Matsumoto T, Yagishita S, et al. 2008. Vascular endothelial growth factor in rabbits during development of corticosteroid-induced osteonecrosis: a controlled experiment. J Rheumatol 35: 2383-2390.
7. Katsube K, Bishop AT, Simari RD, et al. 2005. Vascular endothelial growth factor (VEGF) gene transfer enhances surgical revascularization of necrotic bone. J Orthop Res 23: 469-474. (Pubitemid 40287877)
8. Cao K, Huang W, An H, et al. 2009. Deproteinized bone with VEGF gene transfer to facilitate the repair of early avascular necrosis of femoral head of rabbit. Chin J Traumatol 12: 269-274.
9. Kim HK, Bian H, Aya-ay J, et al. 2009. Hypoxia and HIF-1alpha expression in the epiphyseal cartilage following ischemic injury to the immature femoral head. Bone 45: 280-288.
10. Carano RA, Filvaroff EH,. 2003. Angiogenesis and bone repair. Drug Discov Today 8: 980-989. (Pubitemid 37474243)
11. Xie K, Wei D, Shi Q, et al. 2004. Constitutive and inducible expression and regulation of vascular endothelial growth factor. Cytokine Growth Factor Rev 15: 297-324. (Pubitemid 39140697)
12. Shahbazi M, Fryer AA, Pravica V, et al. 2002. Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection. J Am Soc Nephrol 13: 260-264. (Pubitemid 34042036)
13. Watson CJ, Webb NJ, Bottomley MJ, et al. 2000. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 12: 1232-1235. (Pubitemid 30611801)
14. Awata T, Inoue K, Kurihara S, et al. 2002. A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes 51: 1635-1639. (Pubitemid 34826636)
15. Gardeniers JWM,. 1993. The ARCO perspective for reaching one uniform staging system of osteonecrosis. In:, Scoutens A, Arlet J, Gardeniers JWM, Hughes SPF, editors. Bone circulation and vascularization in normal and pathologic conditions. New York: Plenum Press; p 375-380.
16. Hirota Y, Hotokebuchi T, Sugioka Y,. 1997. Idiopathic osteonecrosis of the femoral head: nationwide epidemiologic studies in Japan. In:, Urbaniak JR, Jones JP, editors. Osteonecrosis: etiology, diagnosis, and treatment, Rosemont, IL: The American Orthopaedic Association; p 51-58.
17. Koo KH, Kim R, Kim YS, et al. 2002. Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment. Clin Rheumatol 21: 299-303.
18. Matsuo K, Hirohata T, Sugioka Y, et al. 1988. Influence of alcohol intake, cigarette smoking, and occupational status on idiopathic osteonecrosis of the femoral head. Clin Orthop Relat Res 234: 115-123.
19. Kim TH, Hong JM, Lee JY, et al. 2008. Promoter polymorphisms of the vascular endothelial growth factor gene is associated with an osteonecrosis of the femoral head in the Korean population. Osteoarthritis Cartilage 16: 287-291. (Pubitemid 351309178)
20. Kawai Y, Sakano S, Korenaga Y, et al. 2007. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas. Eur Urol 52: 1147-1155. (Pubitemid 47332024)
21. Lin JM, Wan L, Tsai YY, et al. 2008. Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration. Am J Ophthalmol 145: 1045-1051.
22. Carter KW, McCaskie PA, Palmer LJ,. 2006. JLIN: a java based linkage disequilibrium plotter. BMC Bioinformatics 7: 60.
23. Stephens M, Smith NJ, Donnelly P,. 2001. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68: 978-989. (Pubitemid 32289743)
24. Faul F, Erdfelder E, Lang AG, et al. 2007. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39: 175-191.
25. Prior SJ, Hagberg JM, Paton CM, et al. 2006. DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption. Am J Physiol Heart Circ Physiol 290: H1848-H1855.
26. French D, Hamilton LH, Mattano LA Jr, et al. 2008. A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood 111: 4496-4499.
27. Ferrari P, Schroeder V, Anderson S, et al. 2002. Association of plasminogen activator inhibitor-1 genotype with avascular osteonecrosis in steroid-treated renal allograft recipients. Transplantation 74: 1147-1152. (Pubitemid 35216110)
28. Hirata T, Fujioka M, Takahashi KA, et al. 2007. ApoB C7623T polymorphism predicts risk for steroid-induced osteonecrosis of the femoral head after renal transplantation. J Orthop Sci 12: 199-206. (Pubitemid 46835462)
29. Asano T, Takahashi KA, Fujioka M, et al. 2003. Genetic analysis of steroid-induced osteonecrosis of the femoral head. J Orthop Sci 8: 329-333. (Pubitemid 36702081)
30. Kawedia JD, Kaste SC, Pei D, et al. 2011. Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia. Blood 117: 2340-2347.
31. Fiore M, Mancinelli R, Aloe L, et al. 2009. Hepatocyte growth factor, vascular endothelial growth factor, glial cell-derived neurotrophic factor and nerve growth factor are differentially affected by early chronic ethanol or red wine intake. Toxicol Lett 188: 208-213.
32. Gu JW, Bailey AP, Sartin A, et al. 2005. Ethanol stimulates tumor progression and expression of vascular endothelial growth factor in chick embryos. Cancer 103: 422-431. (Pubitemid 40129304)
33. Lambrechts D, Storkebaum E, Morimoto M, et al. 2003. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Genet 34: 383-394. (Pubitemid 36935331)
34. Howell WM, Bateman AC, Turner SJ, et al. 2002. Influence of vascular endothelial growth factor single nucleotide polymorphisms on tumour development in cutaneous malignant melanoma. Genes Immun 3: 229-232. (Pubitemid 38961136)
35. Wongpiyabovorn J, Yooyongsatit S, Ruchusatsawat K, et al. 2008. Association of the CTG (-2578/-460/+405) haplotype within the vascular endothelial growth factor gene with early-onset psoriasis. Tissue Antigens 72: 458-463.
36. Guzman-Morales J, El-Gabalawy H, Pham MH, et al. 2009. Effect of chitosan particles and dexamethasone on human bone marrow stromal cell osteogenesis and angiogenic factor secretion. Bone 45: 617-626.
37. Pufe T, Scholz-Ahrens KE, Franke AT, et al. 2003. The role of vascular endothelial growth factor in glucocorticoid-induced bone loss: evaluation in a minipig model. Bone 33: 869-876. (Pubitemid 37543563)
38. Koedam JA, Smink JJ, van Buul-Offers SC,. 2002. Glucocorticoids inhibit vascular endothelial growth factor expression in growth plate chondrocytes. Mol Cell Endocrinol 197: 35-44. (Pubitemid 35304775)
39. Leonard MO, Godson C, Brady HR, et al. 2005. Potentiation of glucocorticoid activity in hypoxia through induction of the glucocorticoid receptor. J Immunol 174: 2250-2257. (Pubitemid 40223972)
40. Wang G, Zhang CQ, Sun Y, et al. 2010. Changes in femoral head blood supply and vascular endothelial growth factor in rabbits with steroid-induced osteonecrosis. J Int Med Res 38: 1060-1069.
41. Tamura K, Nakajima S, Hirota Y, et al. 2007. Genetic association of a polymorphism of the cAMP-responsive element binding protein-binding protein with steroid-induced osteonecrosis after kidney transplantation. J Bone Miner Metab 25: 320-325. (Pubitemid 47283271)
42. Asano T, Takahashi KA, Fujioka M, et al. 2003. ABCB1 C3435T and G2677T/A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantation. Pharmacogenetics 13: 675-682. (Pubitemid 38316511)